Intravenous -acetylcysteine in severe cutaneous drug reaction treatment: A case series
Drug-induced serious adverse reaction is an unpleasant event with high rate of mortality. Stevens–Johnson Syndrome and toxic epidermal necrolysis are most common among the serious adverse drug reactions. There is no selective drug therapy for the management of serious adverse drug reactions-associat...
Main Authors: | Md Jahidul Hasan, Raihan Rabbani |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-06-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X20934708 |
Similar Items
-
Use of intravenous N-acetylcysteine in acute severe hepatitis due to severe dengue infection: a case series
by: D. M. D. I. B. Dissanayake, et al.
Published: (2021-09-01) -
Atopic diseases: Risk factor in developing adverse reaction to intravenous N-Acetylcysteine
by: F Gheshlaghi, et al.
Published: (2006-05-01) -
A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
by: Joseph Gabriel Gabriel MD, et al.
Published: (2017-05-01) -
Treatments for Severe Cutaneous Adverse Reactions
by: Yung-Tsu Cho, et al.
Published: (2017-01-01) -
Bloodstream infection with pandrug-resistant Alcaligenes faecalis treated with double-dose of tigecycline
by: Md Jahidul Hasan, et al.
Published: (2019-01-01)